News Focus
News Focus
Followers 45
Posts 1535
Boards Moderated 0
Alias Born 11/25/2013

Re: north40000 post# 262878

Monday, 04/06/2020 9:18:03 AM

Monday, April 06, 2020 9:18:03 AM

Post# of 447401
North
Great thoughts and appreciate your input.
As you stated , you don’t know how to separate V vs g sales.
I’m a pharmacist and never in my 28 years of practice have I seen where a pharmacist must dispense molecule a brand X for one indication and molecule a brand Y for another indication but here is the closest thing I’ve seen:

Bupropion (generic name of a chemical that had benefits for depression and smoking cessation).
Many insurance companies would not cover for a smoking cessation medication but would pay for an antidepressant. The manufacturer distributed the drug under two different brand names. Zyban was the name of the drug for smoking cessation and Wellbutrin was the name for depression. If a physician was prescribing for depression he was supposed to use Wellbutrin. Zyban for smoking.
The problem became that when the insurance company rejected Zyban because they did not cover smoking cessation products in general the prescriber would just change to Wellbutrin and claim depression.
What if in your arrangement H and R agreed to sell their drug under a different name like TrigBan? An agreement is reached that the 2 not be listed as interchangeable with the FDA. Pharmacists would have to give what is prescribed. H and R get VHTG market and Amarin keeps CVD.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News